Researchers combine herpes virus with cancer vaccine to treat brain cancer in children
Researchers in the US and UK are exploring a new type of cancer treatment as part of a £1.1m funded project by combining a herpes virus...
Jun 4, 2024
CAR T cell therapy for pediatric brain cancer warrants further study
Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s...
Jun 3, 2024
FDA approves tovorafenib for most common form of childhood brain tumor
This decision from the federal agency marks the first FDA approval of a systemic therapy to treat patients with pediatric LGG with BRAF...
May 15, 2024
‘Kinder’ treatment for childhood brain cancer to be offered by NHS in England
Dabrafenib with trametinib can halt growth of some tumours for more than three times as long as standard chemotherapy, study shows. Read...
May 14, 2024
Study: Improved Chemotherapy and Surgery Eliminating Need for Radiation for Low-Grade Gliomas
Successful outcomes from evolving surgical and chemotherapy treatments for pediatric low-grade glioma (pLGG) have greatly reduced the...
Mar 8, 2024
First child cured of rare brain tumor 'offers real hope'
The Belgian boy is the first child in the world to have been cured of brainstem glioma, a particularly brutal cancer, according to the...
Feb 22, 2024
Dabrafenib and trametinib – a new treatment on the horizon?
Recent research suggests that there could be a new treatment on the horizon for some children diagnosed with low and high-grade gliomas....
Dec 18, 2023
Tafinlar Plus Mekinist Shows Benefits In Pediatric Glioma
A recent phase 2 trial revealed that the combination of Tafinlar and Mekinist benefitted children with BRAF-mutated low-grade gliomas....
Dec 12, 2023
Promising investigational therapy improves survival in aggressive childhood brain tumor
An international team of investigators has identified a drug candidate that nearly doubles survival rates for patients with diffuse ...
Dec 4, 2023
FDA Gives Priority Review to Tovorafenib in Pediatric Low-Grade Glioma
The FDA has granted priority review to a new drug application (NDA) for single-agent tovorafenib (DAY101) as a treatment for those with...
Nov 6, 2023